Loading data
LNSRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51.66 m USD | 45.96 m USD | 35.72 m USD | 29.44 m USD | 29.49 m USD |
| Cost of revenue | 31.31 m USD | 27.64 m USD | 21.06 m USD | 15.4 m USD | 16.63 m USD |
| Research and development expense | 5.62 m USD | 5.33 m USD | 6.14 m USD | 11.81 m USD | 12.36 m USD |
| Selling, general and administrative expense | 45.16 m USD | 26.49 m USD | 26.1 m USD | 27.17 m USD | 23.89 m USD |
| Operating profit | -24.58 m USD | -10.67 m USD | -12.23 m USD | -20.18 m USD | -19.65 m USD |
| Profit before tax | -34.28 m USD | -31.4 m USD | -14.38 m USD | -19.91 m USD | -19.6 m USD |
| Net income (reported basis) | -34.28 m USD | -31.4 m USD | -14.38 m USD | -19.91 m USD | -19.6 m USD |
| Net income attributable to common shareholders | -34.28 m USD | -31.4 m USD | -14.38 m USD | -19.91 m USD | -19.6 m USD |
| Basic earnings per share | -2.87 USD/share | -2.73 USD/share | -1.31 USD/share | -1.96 USD/share | -2.09 USD/share |
| Diluted earnings per share | -2.87 USD/share | -2.73 USD/share | -1.31 USD/share | -1.96 USD/share | -2.09 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.